All Stories

  1. Coexistence of Myeloid and Lymphoid Neoplasms: A Single-Center Experience

    Article • Advances in Hematology, November 2019, Hindawi Publishing Corporation

    Eirini Glezou, Professor Panagiotis Tsirigotis , Vasiliki Pappa

  2. Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine

    Article • Leukemia & Lymphoma, April 2019, Taylor & Francis

    Vasiliki Pappa, Dr Maria K Angelopoulou, Dr Mark W Lowdell, Professor Panagiotis Tsirigotis

  3. Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system

    Article • Leukemia & Lymphoma, November 2018, Taylor & Francis

    Vasiliki Pappa, Stamatis Karakatsanis, Dr Eleftheria Hatzimichael

  4. Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis—A Case Report

    Article • Case Reports in Hematology, November 2018, Hindawi Publishing Corporation

    Professor Periklis G Foukas, Vasiliki Pappa, Eirini Glezou

  5. Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De-Novo, Particularly Low-Grade Myelodysplastic Syndromes

    Article • Cytometry Part B Clinical Cytometry, October 2018, Wiley

    Vasiliki Pappa

  6. The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group

    Article • Hematological Oncology, September 2018, Wiley

    Vasiliki Pappa, Dr Eleftheria Hatzimichael

  7. Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis

    Article • Hematological Oncology, June 2018, Wiley

    Vasiliki Pappa, Dr Maria K Angelopoulou, Dr Eleftheria Hatzimichael

  8. The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group

    Article • American Journal of Hematology, May 2018, Wiley

    Vasiliki Pappa, Dr Eleftheria Hatzimichael

  9. ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics

    Article • Leukemia & Lymphoma, February 2018, Taylor & Francis

    Vasiliki Pappa

  10. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience

    Article • Hematological Oncology, February 2017, Wiley

    Dr Marie-Christine Kyrtsonis, Dr Maria K Angelopoulou, Dimitrios Grenzelias, Vasiliki Pappa, Dr Eleftheria Hatzimichael

  11. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis

    Article • Disease Markers, January 2017, Hindawi Publishing Corporation

    Vasiliki Pappa, Eirini Glezou